Key facts
- This page summarizes FR Capital Holdings, L.P.'s Form 4 filing for Notable Labs, Ltd..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jan 2024, 17:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Additional SEC filing notes
Section 16 status
FR Capital Holdings, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
FR Capital Holdings, L.P. (the "Reporting Person") is the investment manager to First Round Capital V, LP, a Delaware limited partnership ("FRCV"), and First Round Capital VIII-F, LP, a Delaware limited partnership ("FRCVIIIF"). Josh Kopelman and William Trenchard are the managing members of the Reporting Person. As of January 2, 2024, FRCV held 363,436 ordinary shares, par value NIS 0.35 each ("Ordinary Shares") of Notable Labs, Ltd. and FRCVIIIF held 518,520 Ordinary Shares. The Reporting Person's and Messrs. Kopelman and Trenchard's beneficial ownership is limited to their pecuniary interest, if any, in such securities.
Footnote F2
On January 2, 2024, FRCV sold 18,535 Ordinary Shares and FRCVIIIF sold 31,465 Ordinary shares, each at a weighted average price of $1.8934 per share. These shares were sold in multiple transactions at prices ranging from $1.84 to $1.9514, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
SEC remarks
This "Exit" Form 4 is voluntarily filed to report that the Reporting Person is no longer a 10% owner of the Issuer.